Laura K. Whited

Post-transplantation cyclophosphamide reduces the incidence of acute graft-versus-host disease in patients with acute myeloid leukemia/myelodysplastic syndromes who receive immune checkpoint inhibitors after allogeneic hematopoietic stem cell transplantation

M. Suarez‐Almazor, M. Konopleva, G. Garcia-Manero, 2021, Journal for ImmunoTherapy of Cancer.

Population pharmacokinetics of cefepime in febrile neutropenia: implications for dose-dependent susceptibility and contemporary dosing regimens.

David R. Jones, M. Scheetz, P. Kiel, 2017, International journal of antimicrobial agents.

Pharmacokinetics of Cefepime in Patients with Cancer and Febrile Neutropenia in the Setting of Hematologic Malignancies or Hematopoeitic Cell Transplantation

Dawn L. Moore, David R. Jones, M. Scheetz, 2016, Pharmacotherapy.

Evaluation of Alemtuzumab Versus Basiliximab Induction: A Retrospective Cohort Study in Lung Transplant Recipients

M. Baz, T. Wozniak, Z. Hashmi, 2015, Transplantation.

Incidence of viral and fungal complications after utilization of alternative donor sources in hematopoietic cell transplantation

C. Hosing, Eric J. Chow, Laura K. Whited, 2020, Pharmacotherapy.

Brincidofovir: understanding its unique profile and potential role against adenovirus and other viral infections.

R. Chemaly, Laura K. Whited, Julio J Alvarez-Cardona, 2020, Future microbiology.

Cardiac toxicity after matched allogeneic hematopoietic cell transplant in the posttransplant cyclophosphamide era

E. Shpall, U. Popat, R. Champlin, 2021, Blood advances.

Feasibility and Implementation of a Multimodal Supportive Care Program to Improve Outcomes in Older Patients Undergoing Allogeneic Stem Cell Transplantation.

D. Marin, E. Shpall, U. Popat, 2021, Transplantation and cellular therapy.

Optimization of intravenous immune globulin use at a comprehensive cancer center.

S. Aitken, B. Figgins, Laura K. Whited, 2019, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.